Now showing items 1-10 of 10

    • Bioequivalence: The Regulatory Career of a Pharmaceutical Concept 

      Carpenter, Daniel Paul; Tobbell, Dominique A. (Johns Hopkins University Press, 2011)
      Generic drugs cannot be marketed without regulatory and clinical demonstration of "bioequivalence." The authors argue that the concept of "bioequivalence" is a joint regulatory and scientific creation, not purely a technical ...
    • The Complications of Controlling Agency Time Discretion: FDA Review Deadlines and Postmarket Drug Safety 

      Carpenter, Daniel Paul; Chattopadhyay, Jacqueline; Moffitt, Susan; Nall, Clayton (Wiley-Blackwell, 2011)
      Public agencies have discretion on the time domain, and politicians deploy numerous policy instruments to constrain it. Yet little is known about how administrative procedures that affect timing also affect the quality of ...
    • Essays on Interservice Rivalry and American Civil-Military Relations 

      Blankshain, Jessica Deighan (2014-06-06)
      How does interservice rivalry affect American civil-military relations? In three essays, I develop theoretical propositions about the relationship between interservice rivalry and civil-military outcomes; propose a two-stage ...
    • Hierarchical Game-Theoretic Models of Transparency in the Administrative State 

      Tai, Laurence (2013-09-30)
      This dissertation develops three game-theoretic models in each of its three chapters to explore the strategic implications of transparency in the administrative state. Each model contains a similar set of three players: a ...
    • Is Health Politics Different? 

      Carpenter, Daniel Paul (Annual Reviews, 2012)
      The aging of the global population, combined with changes in technology and cultural understandings of disease and the body, have thrust discussion and contestation over health into the center of local, national, and global ...
    • Reputation and Public Administration 

      Carpenter, Daniel Paul; Krause, George A. (Wiley-Blackwell, 2011)
      This article examines the application of organizational reputation to public administration. Organizational reputation is defined as a set of beliefs about an organization’s capacities, intentions, history, and mission ...
    • Structured to Fail? Explaining Regulatory Performance under Competing Mandates 

      Carrigan, Christopher (2012-08-06)
      Following each of three major disasters--the financial crisis, the Gulf oil spill, and the nuclear meltdown in Japan--policymakers responded by overhauling the associated regulatory infrastructure. In each case, the response ...
    • Time series analyses of the effect of FDA communications on use of prescription weight loss medications 

      Block, Jason Perry; Choudhry, Niteesh Kumar; Carpenter, Daniel Paul; Fischer, Michael Adam; Brennan, Troyen Anthony; Tong, A. Y.; Matlin, O. S.; Shrank, W (Wiley-Blackwell, 2014)
      OBJECTIVE: To determine the impact of FDA safety communications regarding the weight loss medications sibutramine and orlistat. METHODS: The 2008 to 2011 pharmacy claims data from CVS Caremark were used to determine the ...
    • A Unique Researcher Identifier for the Physician Payments Sunshine Act 

      Carpenter, Daniel Paul; Joffe, Steven (American Medical Association (AMA), 2011)
      The Physician Payments Sunshine Act (PPSA) promises a new era of transparency for the US health care system. Signed into law on March 23, 2010, the PPSA is part of the Patient Protection and Affordable Care Act of 2009.1 ...
    • Why Do Bigger Firms Receive Faster Drug Approvals? 

      Carpenter, Daniel Paul; Feinstein, Brian; Moore, Colin; Turenne, Marc; Yohai, Ian; Zucker, Evan James (2004)
      We test several explanations for the commonly observed pattern that larger firms receive shorter FDA approval times for the drugs they submit. Candidate explanations include capture and rent-seeking and “external-signals” ...